Vol 5, No 3 (2013)
Mol Cell Pharmacol
Table of Contents
Research Articles
| The Immunosuppressant FTY720 (Fingolimod) Induces Nuclear Exit of the Proto-oncogene SET/I2PP2A | Abstract PDF |
| B. Daniël Lam, Eloise C. Anthony, Peter L. Hordijk | 95-107 |
Reviews
| Metabolic Stress and Disorders Related to Alterations in Mitochondrial Fission or Fusion | Abstract PDF |
| Mansi Babbar, M. Saeed Sheikh | 109-133 |
FDA Corner
| FDA Approves Adempas to Treat Pulmonary Hypertension | Abstract PDF |
| 135 |
| FDA Approves Opsumit to Treat Pulmonary Arterial Hypertension | Abstract PDF |
| 135-136 |
| FDA Approves Nexavar to Treat Type of Thyroid Cancer | Abstract PDF |
| 136 |
| FDA Approves New Treatment for Hepatitis C Virus | Abstract PDF |
| 137-138 |
| FDA Approves Sovaldi for Chronic Hepatitis C | Abstract PDF |
| 138-139 |
Our partner: Crossroads Pharmacy 2800 Hwy 101, Rogersville, AL 35652 LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 Copyright © 2008 LumiText Publishing. All rights reserved.